key: cord-0962102-gquo184w authors: Cao, Canhui; Huang, Liang; Liu, Kui; Ma, Ke; Tian, Yuan; Qin, Yu; Sun, Haiyin; Ding, Wencheng; Gui, Lingli; Wu, Peng title: Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains date: 2020-06-02 journal: Genes Dis DOI: 10.1016/j.gendis.2020.05.006 sha: ef62fd9aa48b9b137e7af32ac5d64af90a37ff49 doc_id: 962102 cord_uid: gquo184w Abstract As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to disperse globally with worrisome speed, identifying amino acid variations in the virus could help to understand the characteristics of it. Here, we studied 489 SARS-CoV-2 genomes obtained from 32 countries from the Nextstrain database and performed phylogenetic tree analysis by clade, country, and genotype of the surface spike glycoprotein (S protein) at site 614. We found that virus strains from mainland China were mostly distributed in Clade B and Clade undefined in the phylogenetic tree, with very few found in Clade A. In contrast, Clades A2 (one case) and A2a (112 cases) predominantly contained strains from European regions. Moreover, Clades A2 and A2a differed significantly from those of mainland China in age of infected population (P = 0.0071, mean age 40.24 to 46.66), although such differences did not exist between the US and mainland China. Further analysis demonstrated that the variation of the S protein at site 614 (QHD43416.1: p.614D>G) was a characteristic of stains in Clades A2 and A2a. Importantly, this variation was predicted to have neutral or benign effects on the function of the S protein. In addition, global quality estimates and 3D protein structures tended to be different between the two S proteins. In summary, we identified different genomic epidemiology among SARS-CoV-2 strains in different clades, especially in an amino acid variation of the S protein at 614, revealing potential viral genome divergence in SARS-CoV-2 strains. In late December 2019, an unknown pneumonia-like disease linked to a novel 26 coronavirus was first identified. The disease, now named Coronavirus Disease 2019 27 , was found to be caused by severe acute respiratory syndrome 28 coronavirus 2 (SARS-CoV-2) 1 . By 27-28 February 2020, the virus had caused more infected patients, scientists have found that patients infected with COVID-19 had high 48 amounts of proinflammatory cytokines (IL1B, IFNγ, IP10, and MCP1), probably 49 leading to the responses of activated T-helper-1 (Th1) cells 13 . However, the 50 pathogenic mechanism of the disease and reason for its rapid spread remain unclear. The world map of the SARS-CoV-2 relating clade was performed in Nextstrain 81 (https://nextstrain.org/ncov) 17, 18 . Geographic resolution used division as a parameter. The map, pie chart, and transmissions were saved with default settings. words "does not affect," and "does not reduce" were classified as a neutral effect. PolyPhen-2 also used the sequence of QHD43416.1 and p.614D>G site information. The closer the score is to 1.0, the greater the effect on protein function, and the closer 100 the score is to 0, the smaller the effect on protein function. China (Table 2 ). In addition, based on the map of infection clades worldwide ( torsion scores were -2.02 and -1.99, respectively. However, local quality of the two proteins was similar ( Figure 4B ). shows higher binding affinity than SARS-CoV to ACE2 12 . Therefore, we believe that tree of SARS-CoV-2 genomes from Nextstrain, the cases were colored by countries. Branch labels were clades. Glycine (G) Glutamic ORF8: L84S N: S202N ORF1b: P1427L, Y1464C ORF1a: L3606F ORF1a: V378I ORF3a: G251V S: D614G ORF1b: P314L N: R203K, G204R M: T175M Glycine (G) Glutamic acid (D) GenBank: QHD43416.1 QHD43416.1: p G) Glutamic acid (D)